The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis

The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis

BackgroundTreatment choice for metastatic renal cell carcinoma (mRCC) patients is still based on baseline clinical and laboratory factors.MethodsBy a pre-specified analysis of the Meet-URO 15 multicentric retrospective study enrolling 571 pretreated mRCC patients receiving nivolumab, baseline and ea...

Full description

Bibliographic Details
Main Authors: Sara Elena Rebuzzi, Alessio Signori, Marco Stellato, Daniele Santini, Marco Maruzzo, Ugo De Giorgi, Paolo Pedrazzoli, Luca Galli, Paolo Andrea Zucali, Emanuela Fantinel, Claudia Carella, Giuseppe Procopio, Michele Milella, Francesco Boccardo, Lucia Fratino, Roberto Sabbatini, Riccardo Ricotta, Stefano Panni, Francesco Massari, Mariella Sorarù, Matteo Santoni, Alessio Cortellini, Veronica Prati, Hector Josè Soto Parra, Francesco Atzori, Marilena Di Napoli, Orazio Caffo, Marco Messina, Franco Morelli, Giuseppe Prati, Franco Nolè, Francesca Vignani, Alessia Cavo, Giandomenico Roviello, Miguel Angel Llaja Obispo, Camillo Porta, Sebastiano Buti, Giuseppe Fornarini, Giuseppe Luigi Banna
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
renal cell carcinoma
immunotherapy
dynamics
inflammatory
NLR
prognostic
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.955501/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.955501/full

Similar Items